Current Drug Delivery
Title:Combining Drug-Loaded Nanobubbles and Extracorporeal Shock Waves for Difficult-to-Treat Cancers
Volume: 15 Issue: 6
Author(s): Roberta Cavalli*, Francesca Marano, Monica Argenziano, Alessandra Varese, Roberto Frairia and Maria Graziella Catalano
Affiliation:
- Department of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125 Turin,Italy
Export Options
About this article
Cite this article as:
Cavalli Roberta*, Marano Francesca , Argenziano Monica , Varese Alessandra, Frairia Roberto and Catalano Graziella Maria , Combining Drug-Loaded Nanobubbles and Extracorporeal Shock Waves for Difficult-to-Treat Cancers, Current Drug Delivery 2018; 15 (6) . https://dx.doi.org/10.2174/1567201814666171018120430
DOI https://dx.doi.org/10.2174/1567201814666171018120430 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Are Selenoproteins Important for the Cancer Protective Effects of Selenium?
Current Nutrition & Food Science The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?
Current Drug Targets Molecular Dynamics as a Tool in Rational Drug Design: Current Status and Some Major Applications
Current Computer-Aided Drug Design Deregulation of the Akt Pathway in Human Cancer
Current Cancer Drug Targets Structure, Function and Polymorphism of Human Cytosolic Sulfotransferases
Current Drug Metabolism Identification of Critical MicroRNA Gene Targets in Cervical Cancer Using Network Properties
MicroRNA Molecular Pathways Associated with Aggressiveness of Papillary Thyroid Cancer
Current Genomics B Lymphocytes, Potent Antigen Presenting Cells for Preferential Expansion of Allo-Reactive FoxP3+ CD4 Regulatory T Cells
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Editorial on the Occasion of the 20th Anniversary of Endocrine Metabolic Immune Disorders-Drug Targets Journal with a Kaleidoscopic Vision of Selected Publications
Endocrine, Metabolic & Immune Disorders - Drug Targets Radiopharmaceutical: Revolutionary Agents for Diagnosis
Current Radiopharmaceuticals Biosynthesis of Peptide Hormones Derived from Precursor Sequences
Current Medicinal Chemistry Molecular Mechanisms Underlying the Dedifferentiation Process of Isolated Hepatocytes and Their Cultures
Current Drug Metabolism The Role of Fibroblast Growth Factors in Tumor Growth
Current Cancer Drug Targets Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas
Current Cancer Drug Targets The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases
Drug Design Reviews - Online (Discontinued) Pharmacogenomics of Osteoporosis
Current Pharmacogenomics Cancer, Signal Transduction and Nanotechnology
Current Drug Delivery Retinoic Acid Metabolism and Mechanism of Action: A Review
Current Drug Metabolism Drug Transporters and Multiple Drug Resistance in the Most Common Pediatric Solid Tumors
Current Drug Metabolism Detection of Fungal Infections Using Radiolabeled Antifungal Agents
Current Drug Targets